Cloxacillin Market
Global Cloxacillin Market Size, Share & Trend Analysis Report by Purity (Greater Than or Equal to 97%, and Greater Than or Equal to 98%), By Dosage Form (Injection, Tablets, and Others), Forecast (2022-2028)
The global cloxacillin market is expected to grow at a considerable CAGR during the forecast years. Cloxacillin is broad-spectrum antibiotic penicillin. It is used for the treatment of patients suffering from skin, stomach, and respiratory tract bacterial infections including impetigo, cellulitis, pneumonia, septic arthritis, and otitis externa. One of the major factors for the growth of the global cloxacillin market is the increasing demand for cloxacillin medicines for the treatment of acute bacterial skin and soft tissue infection. In addition, the emergence of drug-resistant bacteria has also increased the demand for cloxacillin. According to the Antibiotic Resistant (AR) Threats Report published by the Center for Disease Control and Prevention (CDC) in 2019, there are around 2.8 million people suffering from antibiotic-resistant infection every year in the US causing more than 35,000 mortalities due to AR infections. The AR infection can affect anyone at any stage of life due to which the demand for cloxacillin is increased for anti-infective therapy.
Impact of COVID-19 on Global Cloxacillin Market
COVID-19 has impacted the global economy due to a slowdown in the manufacturing of various industries. Healthcare came under the essential services so the manufacturing of cloxacillin was continuous throughout the pandemic. The demand for cloxacillin was regular as the patients suffering from bacterial infections were constant.
Segmental Outlook
The global cloxacillin market is segmented based on purity and dosage form. Based on the purity, the market is sub-segmented into greater than or equal to 97%, and greater than or equal to 98%. Based on the dosage form, the market is sub-segmented into injection, tablets, and others. Others include capsules and syrups. Among these, the greater than or equal to 97% pure cloxacillin segment is expected to hold prominent shares as these are used majorly in the production of anti-infection medicines.
Global Cloxacillin Market by Dosage Form, 2021(%)
The Tablets Segment is Anticipated to Hold a Major Share in the Global Cloxacillin market.
The cloxacillin tablets segment is expected to hold the major share in the global cloxacillin market during the forecast year as tablets are the initial form for the treatment of any disease. The tablets are the most convenient way to deal with the diseases for patients unless they are having difficulties in swallowing tablets. Tablets are a very convenient form for taking medicines while traveling. The tablets also are an easily transportable form of medicine for distribution across the globe.
Regional Outlooks
The global cloxacillin market is further segmented based on geography including North America (the US, and Canada), Europe (Italy, Spain, Germany, France, and Others), Asia-Pacific (India, China, Japan, South Korea, and Others), and the Rest of the World (the Middle East & Africa, and Latin America). The North American region is expected to hold the major share in the global cloxacillin market due to the increasing number of patients suffering from pneumonia (pneumococcal) and respiratory tract infection. The cloxacillin is used in combination with other broad-spectrum antibiotic drugs including beta-lactams and fluoroquinolones for the treatment of various drug-resistant bacterial strains in the North American region.
Global Cloxacillin Market Growth by Region, 2022-2028
The Asia Pacific Region is Expected to Grow at a Significant CAGR among the Global Cloxacillin Market During Forecast Year.
The Asia Pacific regional cloxacillin market is anticipated to grow at a significant CAGR during the forecast year due to the increasing number of patients suffering from infections caused by organisms susceptible to cloxacillin and other antibiotic-resistant bacteria. The COVID-19 outbreak has also increased the infection of the respiratory tract in the region. In addition, the high capacity of manufacturing in the emerging economies including India and China in the Asia Pacific region, from where the distribution of cloxacillin is expected to increase is expected to propel the growth of the Asia Pacific regional cloxacillin market.
Market Players Outlook
The major companies serving the global Cloxacillin market include AstraZeneca group Co., Bristol Myers Squibb (BMS), Canagen Pharmaceuticals Inc., GlaxoSmithKline plc., Wellona Pharma, and many others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers & acquisitions, collaborations, fundings, and new product launches. For instance, in December 2020, AstraZeneca acquired Alexion Pharmaceuticals Inc. to increase its research and development capabilities to provide better treatment to patients.
The Report Covers
- Market value data analysis of 2021 and forecast to 2028.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global cloxacillin market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market
1. Report Summary
- Current Industry Analysis and Growth Potential Outlook
- Impact of COVID-19 on The Global Cloxacillin Market
- Recovery Scenario of Global Cloxacillin Market
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. BY Region
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
3. Competitive Landscape
3.1. AstraZeneca group Co.
3.1.1. Overview
3.1.2. Financial Analysis
3.1.3. SWOT Analysis
3.1.4. Recent Developments
3.2. Bristol Myers Squibb (BMS)
3.2.1. Overview
3.2.2. Financial Analysis
3.2.3. SWOT Analysis
3.2.4. Recent Developments
3.3. Canagen Pharmaceuticals Inc.
3.3.1. Overview
3.3.2. Financial Analysis
3.3.3. SWOT Analysis
3.3.4. Recent Developments
3.4. GlaxoSmithKline plc.
3.4.1. Overview
3.4.2. Financial Analysis
3.4.3. SWOT Analysis
3.4.4. Recent Developments
3.5. Wellona Pharma
3.5.1. Overview
3.5.2. Financial Analysis
3.5.3. SWOT Analysis
3.5.4. Recent Developments
3.6. Key Strategy Analysis
3.7. Impact of Covid-19 on Key Players
4. Market Segmentation
4.1. Global Cloxacillin Market by Purity
4.1.1. Greater Than or Equal to 97%
4.1.2. Greater Than or Equal to 98%
4.2. Global Cloxacillin Market by Dosage Form
4.2.1. Injection
4.2.2. Tablets
4.2.3. Others (Capsules and Syrup)
5. Regional Analysis
5.1. North America
5.1.1. The US
5.1.2. Canada
5.2. Europe
5.2.1. UK
5.2.2. Germany
5.2.3. Italy
5.2.4. Spain
5.2.5. France
5.2.6. Rest of Europe
5.3. Asia-Pacific
5.3.1. China
5.3.2. India
5.3.3. Japan
5.3.4. South Korea
5.3.5. Rest of Asia-Pacific
5.4. Rest of the World
6. Company Profiles
6.1. Alpha-Pharma Healthcare
6.2. Alfasigma S.p.A
6.3. Apotex group of Co.
6.4. Cadila Helthcare Ltd. (CHL)
6.5. Cipla Ltd.
6.6. CSL Ltd.
6.7. G. G. Chemicals Pvt. Ltd.
6.8. Merck & Co., Inc.
6.9. Novartis International AG
6.10. Shandong Zhi Shang Chemical Co. Ltd.
6.11. Shree Nath Life Sciences Pvt. Ltd.
6.12. Syschem (India) Ltd.
6.13. Teva Pharmaceuticals Industries Ltd.
6.14. Vysali Pharmaceuticals Ltd.
1. GLOBAL CLOXACILLIN MARKET RESEARCH AND ANALYSIS BY PURITY, 2021-2028 ($ MILLION)
2. GLOBAL 97% OR MORE PURE CLOXACILLIN MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
3. GLOBAL 98% OR MORE PURE CLOXACILLIN MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
4. GLOBAL CLOXACILLIN MARKET RESEARCH AND ANALYSIS BY DOSAGE FORM, 2021-2028 ($ MILLION)
5. GLOBAL CLOXACILLIN INJECTION MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
6. GLOBAL CLOXACILLIN TABLETS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
7. GLOBAL OTHER CLOXACILLIN MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
8. GLOBAL CLOXACILLIN MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2021-2028 ($ MILLION)
9. NORTH AMERICAN CLOXACILLIN MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
10. NORTH AMERICAN CLOXACILLIN MARKET RESEARCH AND ANALYSIS BY PURITY, 2021-2028 ($ MILLION)
11. NORTH AMERICAN CLOXACILLIN MARKET RESEARCH AND ANALYSIS BY DOSAGE FORM, 2021-2028 ($ MILLION)
12. EUROPEAN CLOXACILLIN MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
13. EUROPEAN CLOXACILLIN MARKET RESEARCH AND ANALYSIS BY PURITY, 2021-2028 ($ MILLION)
14. EUROPEAN CLOXACILLIN MARKET RESEARCH AND ANALYSIS BY DOSAGE FORM, 2021-2028 ($ MILLION)
15. ASIA-PACIFIC CLOXACILLIN MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
16. ASIA-PACIFIC CLOXACILLIN MARKET RESEARCH AND ANALYSIS BY PURITY, 2021-2028 ($ MILLION)
17. ASIA-PACIFIC CLOXACILLIN MARKET RESEARCH AND ANALYSIS BY DOSAGE FORM, 2021-2028 ($ MILLION)
18. REST OF THE WORLD CLOXACILLIN MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
19. REST OF THE WORLD CLOXACILLIN MARKET RESEARCH AND ANALYSIS BY PURITY, 2021-2028 ($ MILLION)
20. REST OF THE WORLD CLOXACILLIN MARKET RESEARCH AND ANALYSIS BY DOSAGE FORM, 2021-2028 ($ MILLION)
1. IMPACT OF COVID-19 ON GLOBAL CLOXACILLIN MARKET, 2021-2028 ($ MILLION)
2. IMPACT OF COVID-19 ON GLOBAL CLOXACILLIN MARKET BY SEGMENT, 2021-2028 ($ MILLION)
3. RECOVERY OF GLOBAL CLOXACILLIN MARKET, 2021-2028 (%)
4. GLOBAL CLOXACILLIN MARKET SHARE BY PURITY, 2021 VS 2028 (%)
5. GLOBAL 97% OR MORE PURE CLOXACILLIN MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
6. GLOBAL 98% OR MORE PURE CLOXACILLIN MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
7. GLOBAL CLOXACILLIN MARKET SHARE BY DOSAGE FORM, 2021 VS 2028 (%)
8. GLOBAL CLOXACILLIN INJECTION MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
9. GLOBAL CLOXACILLIN TABLETS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
10. GLOBAL OTHER CLOXACILLIN MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
11. GLOBAL CLOXACILLIN MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
12. US CLOXACILLIN MARKET SIZE, 2021-2028 ($ MILLION)
13. CANADA CLOXACILLIN MARKET SIZE, 2021-2028 ($ MILLION)
14. UK CLOXACILLIN MARKET SIZE, 2021-2028 ($ MILLION)
15. FRANCE CLOXACILLIN MARKET SIZE, 2021-2028 ($ MILLION)
16. GERMANY CLOXACILLIN MARKET SIZE, 2021-2028 ($ MILLION)
17. ITALY CLOXACILLIN MARKET SIZE, 2021-2028 ($ MILLION)
18. SPAIN CLOXACILLIN MARKET SIZE, 2021-2028 ($ MILLION)
19. REST OF EUROPE CLOXACILLIN MARKET SIZE, 2021-2028 ($ MILLION)
20. INDIA CLOXACILLIN MARKET SIZE, 2021-2028 ($ MILLION)
21. CHINA CLOXACILLIN MARKET SIZE, 2021-2028 ($ MILLION)
22. JAPAN CLOXACILLIN MARKET SIZE, 2021-2028 ($ MILLION)
23. SOUTH KOREA CLOXACILLIN MARKET SIZE, 2021-2028 ($ MILLION)
24. REST OF ASIA-PACIFIC CLOXACILLIN MARKET SIZE, 2021-2028 ($ MILLION)
25. REST OF THE WORLD CLOXACILLIN MARKET SIZE, 2021-2028 ($ MILLION)
